The Global Immune Check Point Inhibitors Market was valued at $29,803.71 million in 2020, and is projected to reach $1,40,890.10 million by 2028, registering a CAGR of 16% from 2022 to 2028. Immune checkpoints are proteins that play an important role in regulating the immune system. In cancer, the immune checkpoint is activated and suppresses […]
